IP Library › Granted Patent US 11,304,991
Granted Patent B2
US 11,304,991 · App. 16/947,808 · Granted Apr 19, 2022

Antimicrobial compositions and methods of use thereof

Inventors: Vincent C. Bond (Stone Mountain, GA); Michael Powell (Douglasville, GA); Ming Bo Huang (Atlanta, GA); Syed Ali (New Iberia, LA); Martin N. Shelton (Mountlake Terrace, WA)
Assignee: MOREHOUSE SCHOOL OF MEDICINE
A61K38/162A61K38/08A61K45/06A61K47/60C07K7/06C12N7/00C12N2740/16032Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,304,991
App. No.
16/947,808
Granted
Apr 19, 2022
Kind
B2
Abstract

The present application discloses a method for treating microbial infection using an antimicrobial composition comprises antimicrobial peptide which contains at least one VGFPV motif.

Claims (11)

1. A method of treating a gram positive or gram negative bacterial infection, comprising:

administering to a subject in need thereof an effective amount of an antimicrobial peptide comprising the amino acid sequence of SEQ ID NO: 3 and a cell penetrating peptide (CPP) domain.

2. The method of claim 1 , wherein said antimicrobial peptide comprises the amino acid sequence of SEQ ID NO: 5.

3. The method of claim 1 , wherein said antimicrobial peptide further comprises a second antimicrobial domain, wherein said second antimicrobial domain is different from said first antimicrobial domain.

4. The method of claim 1 , wherein said antimicrobial peptide is administered in combination with another antimicrobial agent.

5. The method of claim 4 , wherein said another antimicrobial agent is another antimicrobial peptide.

6. The method of claim 4 , wherein said antimicrobial peptide is a PEGylated peptide.

7. A method of treating a gram positive or gram negative bacterial infection, comprising:

administering to a subject in need of such treatment an effective amount of an in vivo expression vector that encodes an antimicrobial peptide comprising the amino sequence of SEQ ID NO: 3 and a cell penetrating peptide (CPP) domain,

wherein said in vivo expression vector expresses said antimicrobial peptide in said subject.

8. The method of claim 7 , wherein said antimicrobial peptide comprises the amino acid sequence of SEQ ID NO: 5.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2021
From: BOND, VINCENT C.; POWELL, MICHAEL; HUANG, MING BO; ALI, SYED; SHELTON, MARTIN NEVILLE
To: MOREHOUSE SCHOOL OF MEDICINE
Reel/Frame 056601/0526 →
Continuity (5)
Continuation 16241316 · Jan 7, 2019
Continuation 15397359 · Jan 3, 2017
Continuation 14156119 · Jan 15, 2014
Continuation 13267977 · Oct 7, 2011
Related Publication 20210000914A1 · Jan 7, 2021
Cited By (2)
US 12,187,767 US 12,303,546